Prime editing, a versatile form of gene editing that can correct most known disease-causing genetic mutations, now has a new vehicle to deliver its machinery into cells in living animals. A team of ...

Regeneron Pharmaceuticals will use Mammoth Biosciences’ CRISPR-based ultracompact gene editing platform to develop in vivo therapies for tissues and cell types beyond the liver, the companies said, ...

A team of researchers has adapted engineered virus-like particles (eVLPs)—that they had previously designed to carry base editors—to deliver prime editors to cells in mice at a high enough efficiency ...